Daiwa Securities Group Inc. Alkermes Plc. Transaction History

Daiwa Securities Group Inc.

$27.1 Billion
Q2 2025

A detailed history of Daiwa Securities Group Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 593 shares of ALKS stock, worth $18,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares

593

Previous 534 11.05%

Holding current value

$18,685

Previous $18,000 5.56%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$26.59 - $32.65 $1,568 - $1,926	59 Added 11.05%	593 $17,000
Q4 2024 Feb 07, 2025	SELL	$25.7 - $31.46 $326,569 - $399,762	-12,707 Reduced 95.97%	534 $15,000
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $110,448 - $137,040	4,800 Added 56.87%	13,241 $371,000
Q2 2024 Aug 07, 2024	SELL	$23.21 - $27.24 $464 - $544	-20 Reduced 0.24%	8,441 $203,000
Q1 2024 May 02, 2024	BUY	$26.4 - $32.56 $176,880 - $218,152	6,700 Added 380.47%	8,461 $229,000
Q4 2023 Jan 31, 2024	BUY	$23.37 - $28.68 $25,707 - $31,548	1,100 Added 166.41%	1,761 $49,000
Q4 2022 Feb 06, 2023	BUY	$21.94 - $26.24 $1,140 - $1,364	52 Added 8.54%	661 $17,000
Q2 2022 Aug 09, 2022	BUY	$26.4 - $30.54 $3,616 - $4,183	137 Added 29.03%	609 $18,000
Q4 2021 Feb 03, 2022	SELL	$21.47 - $32.08 $1,739 - $2,598	-81 Reduced 14.65%	472 $11,000
Q3 2021 Nov 05, 2021	BUY	$23.37 - $32.13 $5,935 - $8,161	254 Added 84.95%	553 $17,000
Q4 2020 Feb 04, 2021	SELL	$15.39 - $22.1 $9,080 - $13,039	-590 Reduced 66.37%	299 $6,000
Q4 2019 Jan 31, 2020	SELL	$17.29 - $21.74 $89,095 - $112,026	-5,153 Reduced 85.29%	889 $17,000
Q3 2019 Nov 04, 2019	SELL	$19.51 - $24.28 $11,862 - $14,762	-608 Reduced 9.14%	6,042 $118,000
Q2 2019 Jul 24, 2019	SELL	$21.47 - $37.33 $495,699 - $861,875	-23,088 Reduced 77.64%	6,650 $150,000
Q1 2019 Apr 26, 2019	SELL	$28.4 - $36.49 $149,866 - $192,557	-5,277 Reduced 15.07%	29,738 $1.09 Million
Q4 2018 Feb 05, 2019	SELL	$27.94 - $44.61 $62,697 - $100,104	-2,244 Reduced 6.02%	35,015 $1.03 Million
Q3 2018 Nov 01, 2018	SELL	$38.6 - $46.12 $428,035 - $511,424	-11,089 Reduced 22.94%	37,259 $1.58 Million
Q2 2018 Jul 30, 2018	SELL	$40.56 - $51.36 $502,619 - $636,453	-12,392 Reduced 20.4%	48,348 $1.99 Million
Q1 2018 May 02, 2018	BUY	$53.61 - $67.26 $519,856 - $652,220	9,697 Added 19.0%	60,740 $3.52 Million
Q4 2017 Feb 06, 2018	BUY	$47.69 - $55.39 $2.21 Million - $2.57 Million	46,393 Added 997.7%	51,043 $2.79 Million
Q3 2017 Nov 02, 2017	BUY	$49.16 - $54.45 $228,593 - $253,192	4,650	4,650 $236,000

Others Institutions Holding ALKS

# of Institutions

393

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.18B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Alkermes Plc. Transaction History